The integration of nanomaterials like carbon nanotubes, graphene, and metal nanoparticles has dramatically improved the sensitivity and specificity of SPE-based biosensors for detecting crucial breast cancer biomarkers such as HER2, CA15-3, and CEA. The gene discussed is ERBB2; the disease is breast carcinoma.